Gynuity Health Projects

Resources

Resources by Language

Armenian

Expanding Choice in Abortion Services in Armenia

العربية

Medical Abortion Guidebook

Misoprostol for Early Abortion

Postpartum Hemorrhage: A Challenge for Safe Motherhood

Postpartum Hemorrhage: moving from research to reality

PAC in Action Newsletter: Special Issue on Misoprostol PAC Context

Infertility

Infectious Disease

Pregnancy, Delivery, and Post-Natal Care

Misoprostol for Prevention of Postpartum Hemorrhage

Misoprostol for Incomplete Abortion and Miscarriage

Abortion in the Middle East and North Africa

Fever after treatment of postpartum hemorrhage

Blood Loss After Vaginal Delivery

Guidebook on Misoprostol for Treatment of Incomplete Abortion

Menstruation

Technical Assistance Activities Brief

Social Science Research Activities Brief

Materials Development Activities Brief

Policy and Advocacy Activities Brief

Training and Education Activities Brief

Research

Female Genital Mutilation

Family Planning

Emergency Contraceptives

Child Health

Breast Cancer

Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials

Misoprostol for Treatment of Postpartum Hemorrhage

Pregnancy Termination/Abortion

Reproductive Tract Cancers

RTIs/STIs

Women's Health

Youth Issues in Reproductive Health

English

Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2

Misoprostol for Early Abortion

medical-abortion-guidebook-2nd-ed

Annotated Bibliography - Misoprostol for Early Abortion

Medical Abortion in the U.S.: Mifepristone Fact Sheet

Misoprostol and Teratogenicity: Reviewing the Evidence

Map of Mifepristone Approval

List of Mifepristone Approval

Misoprostol for Prevention of Postpartum Hemorrhage

Postpartum Hemorrhage: A Challenge for Safe Motherhood

Postpartum Hemorrhage: moving from research to reality

Misoprostol: A New Addition to Post Abortion Care

PAC in Action Newsletter: Special Issue on Misoprostol PAC Context

Relationship of Hormonal Contraception to HIV

FAQ on Hormonal Contraception and HIV

Issue Brief on Hormonal Contraception and HIV

Outlook Newsletter on Hormonal Contraception and HIV

FAQs on Fatal Infection and Medical Abortion Technical Version

FAQs on Fatal Infection and Medical Abortion Summary

Misoprostol for Women's Health

Route of Misoprostol Administration

Map of Misoprostol Approval

Research

Misoprostol for Incomplete Abortion and Miscarriage

Medical Abortion Program Brief

Postpartum Hemorrhage Program Brief

WHO MODEL LIST OF ESSENTIAL MEDICINES UPDATED TO INCLUDE MISOPROSTOL FOR PPH

Preeclampsia Program Brief

Policy and Advocacy Activities Brief

Materials Development Activities Brief

Social Science Research Activities Brief

Technical Assistance Activities Brief

Training and Education Activities Brief

Infectious Disease Program Brief

Pregnancy Failure and Miscarriage Program Brief

Reference List - Misoprostol for Early Abortion

Blood Loss After Vaginal Delivery

Misoprostol for Treatment of Incomplete Abortion: A Training guide

Fever after treatment of postpartum hemorrhage

Abortion in the Middle East and North Africa

Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru

Improving Current Therapies & Exploring New Options Abortifacient Tech

Expanding Choice in Abortion Services in Armenia

misoprostol for the prevention of pph

Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials

Guidebook on Misoprostol for Treatment of Incomplete Abortion

Annotated Bibliography - Mifepristone Medical Abortion

Misoprostol, Abortion, and the Law

ICMA Third International Conference

Misoprostol as adjunct treatment for treatment of postpartum haemorrhage

Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives

Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2

Abortion With Self-Administered Misoprostol: A Guide For Women

Misoprostol for Primary vs. Secondary PPH

Secondary Prevention/Early Treatment of PPH

Misoprostol added to the WHO Model List of Essential Medicines for the Treatment of PPH

Misoprostol for Treatment of Postpartum Hemorrhage

Reference List - Misoprostol for Treatment of Postpartum Hemorrhage

The Product Problem: Pathways for Making Misoprostol Available for Postpartum Hemorrhage

Abortion: What is the problem?

Misoprostol for prevention and treatment of postpartum hemorrhage: What do we know? What is next?

Misoprostol as first-line treatment for incomplete abortion in Nigeria

Use of Medicines Changing the Face of Abortion

Oral misoprostol as first-line care for incomplete abortion in Burkina Faso

Treatment approaches for preeclampsia in low-resource settings

Sublingual Misoprostol for the Treatment of Postpartum Hemorrhage

FAQ on Misoprostol Detection in Blood

Mife plus miso or miso-alone for abortion induction in pregnancies 12-24 weeks’ LMP-en

Mife plus miso or miso-alone for treatment of intrauterine fetal death 12-24 weeks’ LMP-en

Institutional brochure-en

Medical abortion work in Eastern Europe/Central Asia

Self-Administration of Misoprostol for Prevention of Postpartum Hemorrhage (PPH)

If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of t

Contraception Program Brief

Strategies to prevent postpartum hemorrhage at the community level

ANTENATAL DISTRIBUTION OF MISOPROSTOL FOR SELF-ADMINISTRATION IN HOME BIRTHS

Use of multilevel pregnancy tests (MLPTS) for medical abortion follow-up

español

Medical Abortion Guidebook 2nd-ed

Misoprostol for Early Abortion

Misoprostol and Teratogenicity: Reviewing the Evidence

Misoprostol for Prevention of Postpartum Hemorrhage

Postpartum Hemorrhage: A Challenge for Safe Motherhood

Postpartum Hemorrhage: moving from research to reality

PAC in Action Newsletter: Special Issue on Misoprostol PAC Context

FAQs on Fatal Infection and Medical Abortion - Technical Version

FAQs on Fatal Infection and Medical Abortion - Summary

Research

Misoprostol for Incomplete Abortion and Miscarriage

Policy and Advocacy Activities Brief

Training and Education Activities Brief

Technical Assistance Activities Brief

Medical Abortion Program Brief

Preeclampsia Program Brief

Infectious Disease Program Brief

Pregnancy Failure and Miscarriage Program Brief

Blood Loss After Vaginal Delivery

Fever after treatment of postpartum hemorrhage

Materials Development Activities Brief

Postpartum Hemorrhage Program Brief

Social Science Research Activities Brief

Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru

map of misoprostol approval

Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan

Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials

Guidebook on Misoprostol for Treatment of Incomplete Abortion

Annotated Bibliography - Mifepristone Medical Abortion

WHO MODEL LIST OF ESSENTIAL MEDICINES UPDATED TO INCLUDE MISOPROSTOL FOR PPH

Abortion With Self-Administered Misoprostol: A Guide For Women

Reference List - Misoprostol for Treatment of Postpartum Hemorrhage

Misoprostol for Treatment of Postpartum Hemorrhage

Misoprostol for Treatment of Incomplete Abortion in Guatemala

Map of Mifepristone Approval

Misoprostol for Treatment of Incomplete Abortion: A Training guide

FAQ on Misoprostol Detection in Blood

Mife plus miso or miso-alone for treatment of intrauterine fetal death 12-24 weeks’ LMP-sp

Mife plus miso or miso-alone for abortion induction in pregnancies 12-24 weeks’ LMP-sp

Institutional brochure-sp

List of Mifepristone Approval

FAQs on the Use of Multilevel Pregnancy Tests for Medical Abortion_sp

français

Misoprostol for Early Abortion

Medical Abortion Guidebook 2nd-ed

Misoprostol for Prevention of Postpartum Hemorrhage

Postpartum Hemorrhage: A Challenge for Safe Motherhood

PAC in Action Newsletter: Special Issue on Misoprostol PAC Context

Postpartum Hemorrhage: moving from research to reality

Blood Loss After Vaginal Delivery in French

Misoprostol for Incomplete Abortion and Miscarriage

Fever after treatment of postpartum hemorrhage

Postpartum Hemorrhage Program Brief

Materials Development Activities Brief

Policy and Advocacy Activities Brief

Research

Training and Education Activities Brief

Medical Abortion Program Brief

Preeclampsia Program Brief

Pregnancy Failure and Miscarriage Program Brief

Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan

Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials

Guidebook on Misoprostol for Treatment of Incomplete Abortion

Abortion With Self-Administered Misoprostol: A Guide For Women

Misoprostol for Treatment of Postpartum Hemorrhage

Misoprostol for Treatment of Incomplete Abortion: A Training guide

Mife plus miso or miso-alone for abortion induction in pregnancies 12-24 weeks’ LMP-fr

Mife plus miso or miso-alone for treatment of intrauterine fetal death 12-24 weeks’ LMP-fr

Institutional brochure-fr

Strategies to prevent postpartum hemorrhage at the community level

Bahasa Indonesia

Medical abortion guidebook 2nd_in

Misoprostol for Early Abortion

Instructions

Self-Administration of Misoprostol for Prevention of Postpartum Hemorrhage (PPH)

português

Medical Abortion Guidebook 2nd-ed

PAC in Action Newsletter: Special Issue on Misoprostol PAC Context

Misoprostol for Prevention of Postpartum Hemorrhage

Misoprostol for Incomplete Abortion and Miscarriage

Guidebook on Misoprostol for Treatment of Incomplete Abortion

Abortion With Self-Administered Misoprostol: A Guide For Women

Misoprostol for Treatment of Postpartum Hemorrhage

Postpartum Hemorrhage: moving from research to reality

FAQ on Misoprostol Detection in Blood

Institutional brochure-po

Mife plus miso or miso-alone for treatment of intrauterine fetal death 12-24 weeks’ LMP-po

Mife plus miso or miso-alone for abortion induction in pregnancies 12-24 weeks’ LMP-po

Misoprostol for Early Abortion

Русский

Medical Abortion Guidebook 2nd-ed

Misoprostol for Early Abortion

Misoprostol for Prevention of Postpartum Hemorrhage

Misoprostol for Incomplete Abortion and Miscarriage

Medical Abortion Program Brief

Preeclampsia Program Brief

Pregnancy Failure and Miscarriage Program Brief

Infectious Disease Program Brief

Materials Development Activities Brief

Training and Education Activities Brief

Technical Assistance Activities Brief

Social Science Research Activities Brief

Research

Policy and Advocacy Activities Brief

Expanding Choice in Abortion Services in Armenia

Guidebook on Misoprostol for Treatment of Incomplete Abortion

Misoprostol for Treatment of Postpartum Hemorrhage

Map of Misoprostol Approval

Map of Mifepristone Approval

mife plus miso or miso-alone for abortion induction in pregnancies 12-24 weeks’ LMP-ru

Institutional brochure-ru

List of Mifepristone Approval

Medical abortion work in Eastern Europe/Central Asia

FAQs on the Use of Multilevel Pregnancy Tests for Medical Abortion_ru

Tamil

Misoprostol for Incomplete Abortion and Miscarriage

medical abortion guidebook 2nd ed_ta

românã

Medical Abortion Guidebook

Türkçe

FAQs on Fatal Infection and Medical Abortion - Technical Version

Misoprostol for Incomplete Abortion and Miscarriage

Misoprostol for Prevention of Postpartum Hemorrhage

Misoprostol for Early Abortion

Medical Abortion Guidebook 2nd-ed

Blood Loss After Vaginal Delivery

Fever after treatment of postpartum hemorrhage

Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials

Misoprostol for Treatment of Postpartum Hemorrhage

Postpartum Hemorrhage: moving from research to reality

اردو

Misoprostol for Prevention of Postpartum Hemorrhage

Postpartum Hemorrhage: moving from research to reality

Tiếng Việt

Misoprostol for Prevention of Postpartum Hemorrhage

Blood Loss After Vaginal Delivery in Vietnamese

Fever after treatment of postpartum hemorrhage

Medical Abortion Guidebook 2nd-ed

Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials

Misoprostol for Treatment of Postpartum Hemorrhage